Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Economy & Forex

News : Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
All NewsEconomyCurrencies & ForexEconomic EventsCryptocurrenciesCybersecurityPress Releases

Wall Street's rise from pandemic lows has further to go, say strategists

11/25/2020 | 02:55am EST
Trader Peter Tuchman wears a DOW 30,000 hat as he greets friends outside the New York Stock Exchange (NYSE) in New York

NEW YORK (Reuters) - The S&P 500 is poised to climb 9% between now and the end of 2021 as the anticipated widespread release of a COVID-19 vaccine drives an economic and corporate earnings recovery from the pandemic, according to a Reuters poll of strategists.

After a more than 60% recovery from the March lows of the outbreak to a record high on Nov. 16, the benchmark index is now up about 10% in the year to date.

The benchmark S&P 500 will finish 2021 at 3,900, a 9% gain from its close Monday of 3,577.59, according to the median forecast of 40 strategists polled by Reuters over the last two weeks.

The index is expected to end 2020 at 3,600, close to its current level, according to the poll median.

Recent evidence of high efficacy rates in experimental COVID-19 vaccines has driven an advance in equities this month, and strategists in the poll cited progress in the vaccine as the main factor behind their forecasts.

"They assume a vaccine is widely available starting some time in the second half of 2021," said Sameer Samana, senior global market strategist for Wells Fargo Investment Institute, which has a 2021 year-end forecast for the S&P 500 of 3,900.

With a big pickup in the economy expected to follow, Wall Street is likely "grossly underestimating" next year's rebound in earnings, said Jim Paulsen, chief investment strategist at The Leuthold Group in Minneapolis, who sees the S&P 500 ending next year at 4,100.

"That's one thing I think could be a huge driving force," for stocks, he said.

Wall Street analysts expect S&P 500 earnings to jump 23% in 2021 after falling more than 15% in 2020, according on I/B/E/S data from Refinitiv.

Asked when earnings will return to pre-COVID-19 levels, most respondents said it would happen within a year.

Graphic: When will corporate earnings return to pre-COVID-19 levels in the U.S. stock market?, https://graphics.reuters.com/USA-STOCKS/POLL/jbyprebdzve/chart.png

Recent hopes related to the vaccine have breathed new life into cyclical stocks, such as industrials and energy shares, which investors dumped earlier during the pandemic.

Based on the poll, the Dow Jones industrial average, which was near 30,000 through Monday, will finish next year at 32,500, up around 10% from Monday's close.

Some strategists predict the gains in cyclicals will extend far into 2021, but others say the rotation may not be long-lived.

Jonathan Golub, chief U.S. equity strategist at Credit Suisse Securities, is neutral on cyclicals heading into 2021. In his outlook for next year, he wrote that, "the fundamental case for TECH+ remains compelling" based on expected growth in sales and margins, among other factors. He forecasts the S&P 500 will end next year at 4,050.

The S&P 500 technology sector, which includes Apple Inc. and Microsoft Corp., is up roughly 30% for the year so far and leading gains among sectors, followed by the consumer discretionary sector, which includes Amazon.

Investors were upbeat after Democrat Joe Biden's win in the U.S. presidential election without a "Blue Wave" sweep by Democrats earlier this month, a feeling that's likely to linger if a divided Congress means limited regulatory changes and Biden's Cabinet picks are market-friendly.

On Monday, investors cheered reports that Biden had picked former Federal Reserve Chair Janet Yellen to be the next Treasury secretary.

Strategists in the poll said expectations the Fed will remain accommodative help to bolster the case for equities next year.

"The Fed has said they intend to keep short rates grounded at zero through at least 2023. With ultra low rates, stocks have little competition," said Hank Smith, chief investment officer at Haverford Trust Co. in Radnor, Pennsylvania.

(This version of the story corrects attribution of the poll to Reuters in the headline. The poll was not conducted in collaboration with IPSOS.)

(Reporting by Caroline Valetkevitch; additional reporting by Chuck Mikolajczak, Noel Randewich, Sinead Carew, Stephen Culp and Alden Bentley; additional polling by Richa Rebello and Manjul Paul; editing by Ross Finley and Bernadette Baum)

By Caroline Valetkevitch


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
APPLE INC. -0.24% 128.59 Delayed Quote.-1.36%
CREDIT SUISSE GROUP AG -0.48% 12.35 Delayed Quote.8.86%
DJ INDUSTRIAL -0.29% 30903.16 Delayed Quote.1.48%
IPSOS SA -1.09% 27.2 Real-time Quote.-0.36%
MICROSOFT CORPORATION 0.29% 213.69 Delayed Quote.-2.73%
NASDAQ 100 -0.21% 12870.576016 Delayed Quote.0.08%
NASDAQ COMP. -0.35% 13064.931411 Delayed Quote.1.87%
S&P 500 -0.40% 3779.84 Delayed Quote.1.05%
WELLS FARGO & COMPANY -7.17% 32.235 Delayed Quote.15.14%
Latest news "Economy & Forex"
01:44pNEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY : NJEDA Board Approves NJ ZIP Pilot Program
PU
01:42pOil drops over 2% on China lockdowns, U.S. stimulus concerns
RE
01:35pDating app Bumble reveals steady revenue growth, losses in IPO filing
RE
01:33pU.s. cdc says 1,610,524 individuals have received two doses of covid-19 vaccine as of jan. 15 vs 1,342,086 individuals as of as of jan. 14
RE
01:33pU.S. CDC Says Distributed 31.16 Mln Doses Of Covid-19 Vaccine As Of Jan 15
RE
01:33pU.s. cdc says 10,595,866 individuals have received one or more doses of covid-19 vaccine as of jan. 15 vs 9,690,757 individuals as of as of jan. 14
RE
01:32pU.s. cdc says 1,384,963 doses of covid-19 vaccine administered in long-term care homes as of jan 15 vs 1,225,493 doses administered as of jan 14
RE
01:32pU.s. cdc says administered 12,279,180 doses of covid-19 vaccine as of jan 15 vs 11,148,991 doses administered as of jan 14
RE
01:32pU.s. cdc says distributed 31,161,075 doses of covid-19 vaccine as of jan 15 vs 30,628,175 doses distributed as of jan 14
RE
01:31pGlobal COVID-19 death toll tops 2 million
RE
Latest news "Economy & Forex"